Promonitor QUICK - PoC
Categoría
Diagnostics and Personalised Medicine
Tipo de registro
Biotech Sanitaria
Nombre socio
Producto / Servicio
Promonitor QUICK - PoC
Tipo
Diagnostic
Area terapéutica
Inmunología
Propiedades/Indicación
Point of Care Therapeutic drug monitoring.
Rapid immunochromatography test for the quantitative in human whole blood or serum detection of: infliximab (IFX), Antiinfliximab (IFX) antibodies, adalimumab (ADL) and antiadalimumab (Anti-ADL) antibodies
Rapid immunochromatography test for the quantitative in human whole blood or serum detection of: infliximab (IFX), Antiinfliximab (IFX) antibodies, adalimumab (ADL) and antiadalimumab (Anti-ADL) antibodies
Aplicación
Rapid immunochromatography test based on the quantitative detection of therapeutic drugs or the qualitative detection of anti-drug antibodies in human whole blood or serum
Fase de desarrollo
Registration
Fases desarrolladas en España
R&D
Preclinical
Clinical Validation
Registration
Localización de la Investigación
España
Comercializado
✔
Año de salida al mercado
2021